8. Interesting news
Doctors are prescribing the great outdoors, but that’s not great for everyone
https://www.popsci.com/nature-prescripti…
‘Always read the small print’: a case study of commercial research funding, disclosure and agreements with Coca-Cola
https://www.ncbi.nlm.nih.gov/pubmed/3106…
The World Health Organization knows ‘burnout’ is a problem–but is it a disease?
https://www.popsci.com/burnout-icd-medic…
Busting the myth that depression doesn’t affect people in poor countries
https://www.theguardian.com/society/2019…
Exclusive: Philip Morris suspends social media campaign after Reuters exposes young ‘influencers’
https://www.reuters.com/article/us-phili…
Study pulls back curtain on contracts between Coca-Cola and the researchers it funds
https://www.statnews.com/2019/05/07/coca…
Dietary cholesterol or egg consumption do not increase the risk of stroke, Finnish study finds
A new study Finland shows that a moderately high intake of dietary cholesterol or consumption of up to one egg per day is not associated with an elevated risk of stroke. Furthermore, no association was found in carriers of the APOE4 phenotype, which affects cholesterol metabolism and is remarkably common among the Finnish population.
https://www.sciencedaily.com/releases/20…
Heated tobacco and politics: highlights from Italy
In Italy, a “sunshine act” proposal to make financial links between health care professionals and Industry more transparent has been approved by the Chamber of Deputies and is currently being discussed by the Senate for definitive approval.
https://www.bmj.com/content/365/bmj.l216…
The EU adopts a new Regulation that strictly limits the amount of industrially produced trans fat in all foods sold to EU consumers
The maximum limit corresponds to 2 grams of industrially produced trans fats per 100 grams of fat in food intended for the final consumer and food intended for the supply to retail. Foods must comply by 2 April 2021. See the factsheet for more!
https://ec.europa.eu/food/sites/food/fil…
What do you know about Direct-To-Consumer Genetic Testing?
The present survey evaluates the public health professionals’ knowledge, attitudes and behaviours towards Direct-To-Consumer Genetic Testing (DTC-GT). DTC-GTs are defined as genetic tests that are both marketed and sold directly to the public, including over the counter, without the supervision of a healthcare professional. The survey takes part in The Innovative Partnership for Action Against Cancer (iPAAC) Joint Action, Grant Agreement No. 801520 – HP-JA-2017, aninitiative that is co-funded under the Third Health Programme 2014–2020 of the EU commission and includes 44 partners from 24 European countries. The overall aim of iPAAC is to develop innovative approaches to advance in cancer control, while the key focus is placed on the implementation process among the local, regional and national policymakers. The “Università Cattolica del Sacro Cuore, Rome, Italy, is supporting Istituto Superiore di Sanità (the Italian National Institute of Health) in the task on DTC-GTs. Our institution has designed the present questionnaire in line with the published literature. Previous studies focused mainly on investigating physicians’ or geneticists’ knowledge, attitudes and behaviours regarding DTC-GT. Since the implementation of precision genomics may have profound impact on individuals’ health behaviours as well as preventive healthcare practices, it remains crucial to gather the perspectives of public health professionals about DTC-GT. This anonymous questionnaire includes a first part on personal information and professional activity. In the next sections, you are asked about your knowledge, opinion and behaviour regarding DTC-GTs. You can start the survey by clicking on the following link: https://forms.gle/Dr1mQWHrYxwvgy9e9 Thank you for taking the time to participate in this survey. Your response will be greatly appreciated.
Royal Society of Public Health publishes public mental health report
A report entitled ‘Public Mental Health: Evidence, practice and commissioning’ was recently published at https://www.rsph.org.uk/about-us/news/launch-of-public-mental-health-evidence-practice-and-commissioning.html It summarises the evidence for impacts of mental disorder (including 7-25 year reduced life expectancy) and wellbeing, risk factors for mental disorder, protective factors for mental wellbeing and higher risk groups as well as interventions to treat mental disorder, prevent associated impacts, prevent mental disorder and promote mental wellbeing. It also highlights that most people with mental disorder receive no treatment and the even larger size of the implementation gap for cost effective interventions to prevent mental disorder, associated impacts and promote wellbeing. It covers the reasons for the gap, the impacts and economic savings from improved coverage, and provides recommendations to close the implementation gap. The report has been endorsed by Association of Directors of Public Health, Faculty of Public Health, Health Education England, Local Government Association, Royal College of General Practitioners, Royal College of Psychiatrists and Royal Society for Public Health.
https://www.rsph.org.uk/about-us/news/la…
European Observatory: Averting the AMR crisis
This new policy brief summarizes some of the key policy avenues for tackling antimicrobial resistance (AMR). Following the widely accepted ‘One Health’ approach to combating AMR, the brief aims to support the implementation of national action plans (NAPs) on AMR, drawing on numerous examples of effective policies implemented by European Union Member States and involving the human, animal and environmental health sectors. This policy brief was prepared to support the Romanian EU Council Presidency, which hosted a conference on ‘Next Steps to Making the EU a Good Practice in Combating Resistance to Antimicrobials’ (Bucharest, 1 March 2019). It draws significantly on a forthcoming study, Challenges in Tackling Antimicrobial Resistance: Economic and Policy Responses, being co-produced by the Observatory and the Organisation for Economic Co-operation and Development (OECD).
http://www.euro.who.int/en/about-us/part…
The first year of the Joint Action on Tobacco Control
The Joint Action on Tobacco Control (JATC) was launched in October 2017. This comprehensive EU funded project aims to provide support for the implementation of the Tobacco Products Directive (TPD)* across the 28 EU Member States and to improve the protection of EU Public Health.
The TPD is a complex legislative document that lays down the rules governing the manufacture, presentation and sale of tobacco and related products, while also supporting the functioning of the internal market of tobacco products in the EU. The JATC addresses the issue of tobacco product monitoring at an EU wide level – an activity that would be impossible to be done by one, or a few EU MS by themselves.
This 36-month project constitutes of 9 Work Packages and involves 30 Partners and additional 13 Collaborating Partners, who have an observing and counseling role. Work packages 1-4 have a horizontal structure within the project, aiming at the internal organization, information dissemination and integration of the final outcomes into national policies, while the remaining core work packages target on other functional subjects on tobacco control between member states.
http://http://jaotc.eu/ |